Impact Analysis of Covid-19

The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Degenerative Disc Disease Treatment Market – Insights

Degenerative disc diseases are very frequent and debilitating disorders, and R&D activities surrounding this disease are highly cost intensive. Hence, many fund raising companies and manufacturers are engaged in raising funds for their research regarding the treatment of degenerative disc diseases.

Depending upon the level of pain, degenerative disc disease can be treated with two common processes which are non-surgical and spinal fusion. Non-surgical treatments include medications, physical therapy and chiropractic care. Whereas, spinal fusion is a procedure used to surgically treat degenerative disc disease.

The degenerative disc disease treatment market is expected to exhibit significant growth over the forecast period. This is owing to technological advancements such as artificial discs. For instance, in 2013, Zimmer Biomet launched Mobi-C, a two-level artificial disc for patients with issues at two consecutive spinal disc. Furthermore, manufacturers are focusing on acquisition strategies to strengthen their product portfolios which is expected to drive global degenerative disc disease treatment market growth. For instance, Centinel Spine in October 2017, entered into an asset purchase agreement to acquire the ProDisc Total Disc Replacement portfolio from DePuy Synthes.

The global degenerative disc disease treatment market size was valued at US$ 1,736.4 million in 2019, and is expected to witness a CAGR of 9.0% over the forecast period (2019 – 2027).

Global Degenerative Disc Disease Treatment Market Share (%) Analysis, By Product Type, 2019

Degenerative Disc Disease Treatment  | Coherent Market Insights

Source: Coherent Market Insights Analysis (2019)

An increasing launch of disc replacement surgical devices is expected to drive growth of the global degenerative disc disease treatment market

Various companies are focusing on launching innovative and technologically advanced products to meet the needs of customers, which is expected to propel the degenerative disc disease treatment market growth over the forecast period. For instance, in March 2019, Atlas Spine Inc. announced the launch of HiJak AC expandable cervical interbody fusion device. The product is expandable cervical interbody fusion device used for the spine fusion surgery. The device offers adjustment to both height and lordosis to easily restore lordosis and balance sagittal alignment of the spinal cord.

Global Degenerative Disc Disease Treatment Market - Restraints

Alternative therapies such as physiotherapy and special exercises are also used for treatment of degenerative disc disease, which is expected to hamper growth of the degenerative disc disease treatment market over the forecast period. For instance, according to data published in the Toronto Physiotherapy Journal in January 2014, physiotherapy is the most preferred first line treatment for degenerative disc disease among the aging population.

Global Degenerative Disc Disease Treatment Market - Regional Insights

On the basis of region, the global degenerative disc disease treatment market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America holds a dominant position in the global degenerative disc disease treatment market owing to an increasing number of degenerative disc disease treatments. For instance, in September 2019, DePuy Synthes, a subsidiary of Johnson & Johnson Medical Devices Companies, launched CONDUIT Interbody Platform with EIT Cellular Titanium Technology. The product is designed to mimic natural bone structure and facilitate spinal fusion.

Asia Pacific is the fastest growing region in the global degenerative disc disease treatment market owing to increasing product approvals. For instance, in July 2016, Orthofix International N.V. received regulatory approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) for PHOENIX, a minimally invasive spinal (MIS) fixation system.

Global Degenerative Disc Disease Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2016-2027

Degenerative Disc Disease Treatment  | Coherent Market Insights

 Source: Coherent Market Insights Analysis (2019)

Global Degenerative Disc Disease Treatment Market - Competitive Landscape

Key players operating in the global degenerative disc disease treatment market include Medtronic Plc., Globus Medical Inc., Johnson & Johnson, Zimmer Biomet Holdings, Inc., B. Braun Melsungen AG, RTI Surgical Holdings, Inc., Cousin Biotech, Ulrich Medical USA, Inc., Fresenius Kabi AG and Abbott Laboratories.

Degenerative disc disease is a spinal condition caused by the breakdown of intervertebral discs. The symptoms observed for degenerative disc disease are tingling or numbness in legs or difficulty walking. This disease is diagnosed with physical examination, through X-rays or magnetic resonance imaging (MRI). The degenerative disc disease is most commonly seen in geriatric population and have caused low back pain and neck pain in adults. The common cases of back pain among patients occurs at the lower side of the back. As per American Association of Neurological Surgeons in 2016, 75-85% of the people in the U.S. experience some form of back pain in their life.

Market Dynamics

Increasing prevalence of degenerative disc disease is expected to support the market growth over the forecast period. For instance, according to the National Center for Biotechnology Information report, around 266 million patients worldwide were diagnosed with lumbar degenerative spine disease (DSD) in 2018.

However, high cost associated with degenerative disc disease treatments such as artificial disc replacement and spinal fusion is expected to hamper the market growth in the near future. For instance, the average cost of specific disc replacement surgery procedure ranges between US$ 16,000 to US$ 46,000 in different states of the U.S.

Key features of the study:

  • This report provides in-depth analysis of the global degenerative disc disease treatment  market, market size (US$ Mn), and compound annual growth rate (CAGR (%) for the forecast period, 2019-2027, considering 2018 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by leading players
  • It profiles key players in the global degenerative disc disease treatment market based on the following parameters: company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key players covered as a part of this study include Medtronic Plc., Globus Medical Inc., Johnson & Johnson, Zimmer Biomet Holdings, Inc., B. Braun Melsungen AG, RTI Surgical Holdings, Inc., Cousin Biotech, Ulrich Medical USA, Inc., Fresenius Kabi AG and Abbott Laboratories
  • Insights from this report would allow marketers and management authorities of companies to make informed decisions with respect to future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
  • The global Degenerative Disc Disease Treatment market report caters to various stakeholders in this industry, which include investors, product manufacturers, distributors, and suppliers for global Degenerative Disc Disease Treatment market, research and consulting firms, new entrants, and financial analysts.

Detailed Segmentation:

  • Global Degenerative Disc Disease Treatment  Market, by Product Type:
    • Drugs
      • Acetaminophen
      • NSAIDs
      • Oral steroids
      • Muscle Relaxants
    • Devices
      • Cervical Spine
      • Lumbar Spine
      • Thoracic Spine
      • Spinal Fusion
  • Global Degenerative Disc Disease Treatment  Market, by Region:
    • North America
      • By Country:
        • U.S.
        • Canada
      • By Product Type:
        • Drugs
          • Acetaminophen
          • NSAIDs
          • Oral steroids
          • Muscle Relaxants
        • Devices
          • Cervical Spine
          • Lumbar Spine
          • Thoracic Spine
          • Spinal Fusion
    • Europe
      • By Country:
        • U.K.
        • Germany
        • Italy
        • Spain
        • France
        • Russia
        • Rest of Europe
      • By Product Type:
        • Drugs
          • Acetaminophen
          • NSAIDs
          • Oral steroids
          • Muscle Relaxants
        • Devices
          • Cervical Spine
          • Lumbar Spine
          • Thoracic Spine
          • Spinal Fusion
    • Asia Pacific
      • By Country:
        • Australia
        • India
        • China
        • Japan
        • ASEAN
        • South Korea
        • Rest of Asia Pacific
      • By Product Type:
        • Drugs
          • Acetaminophen
          • NSAIDs
          • Oral steroids
          • Muscle Relaxants
        • Devices
          • Cervical Spine
          • Lumbar Spine
          • Thoracic Spine
          • Spinal Fusion
    • Latin America
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
      • By Product Type:
        • Drugs
          • Acetaminophen
          • NSAIDs
          • Oral steroids
          • Muscle Relaxants
        • Devices
          • Cervical Spine
          • Lumbar Spine
          • Thoracic Spine
          • Spinal Fusion
    • Middle East
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
      • By Product Type:
        • Drugs
          • Acetaminophen
          • NSAIDs
          • Oral steroids
          • Muscle Relaxants
        • Devices
          • Cervical Spine
          • Lumbar Spine
          • Thoracic Spine
          • Spinal Fusion
    • Africa
      • By Country/Region:
        • South Africa
        • Central Africa
        • North Africa
      • By Product Type:
        • Drugs
          • Acetaminophen
          • NSAIDs
          • Oral steroids
          • Muscle Relaxants
        • Devices
          • Cervical Spine
          • Lumbar Spine
          • Thoracic Spine
          • Spinal Fusion
  • Company Profiles
    • Medtronic Plc.*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • Globus Medical Inc.
    • Johnson & Johnson
    • Zimmer Biomet Holdings, Inc.
    • B. Braun Melsungen AG
    • RTI Surgical Holdings, Inc.
    • Cousin Biotech
    • Ulrich Medical USA, Inc.
    • Fresenius Kabi AG
    • Abbott Laboratories

 “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objective and Assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Overview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product Type
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Regulatory Scenario
    • Market Trends
    • Key Developments
    • Ongoing Studies
    • PEST Analysis
    • Porter’s Analysis
  4. Global Degenerative Disc Disease Treatment Market, By Product Type, 2019 – 2027, (US$ Million)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Drugs 
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027 , (US$ Million)
        • Acetaminophen
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027 , (US$ Million)
        • NSAIDs
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027 , (US$ Million)
        • Oral steroids
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027 , (US$ Million)
        • Muscle Relaxants
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027 , (US$ Million)
    • Devices
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027 , (US$ Million)
        • Cervical Spine
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027 , (US$ Million)
        • Lumbar Spine
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027 , (US$ Million)
        • Thoracic Spine
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027 , (US$ Million)
        • Spinal Fusion
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027 , (US$ Million)
  5. Global Degenerative Disc Disease Treatment Market, By Region, 2019 – 2027, (US$ Million)
    • Introduction
      • Market Share Analysis, By Region, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, By Region, 2017 – 2026
      • Regional Trends
    • North America
      • Market Size and Forecast, By Product Type , 2016 – 2027 , (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2027 , (US$ Million)
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast, By Product Type , 2016 – 2027 , (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2027 , (US$ Million)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Product Type , 2016 – 2027 , (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2027 , (US$ Million)
        • China
        • Japan
        • India
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast, By Product Type , 2016 – 2027 , (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2027 , (US$ Million)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Africa
      • Market Size and Forecast, By Product Type , 2016 – 2027 , (US$ Million)
      • Market Size and Forecast, By Country/Region, 2016 – 2027 , (US$ Million)
        • North Africa
        • Central Africa
        • South Africa
    • Middle East
      • Market Size and Forecast, By Product Type , 2016 – 2027 , (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2027 , (US$ Million)
        • GCC Countries
        • Israel
        • Rest of Middle East
  6. Competitive Landscape
    • Company Profiles
      • Medtronic Plc.*
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Globus Medical Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Johnson & Johnson
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Zimmer Biomet Holdings, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • B. Braun Melsungen AG
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • RTI Surgical Holdings, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Cousin Biotech
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Ulrich Medical USA, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Fresenius Kabi AG
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Abbott Laboratories
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
    • Analyst Views
  7. Section
    • References
    • Research Methodology         
    • About Us and Sales Contact

*Browse 17market data tables and 28 figures on “Degenerative Disc Disease Treatment” - Global forecast to 2027”

Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner